Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current views on Parkinson's disease.

D B Calne

    The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
    |February 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Levodopa therapy has advanced Parkinson's disease treatment but presents challenges. This review covers Parkinson's disease causes, mechanisms, and practical drug therapy strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The cardiovascular effects of bromocriptine in Parkinsonism.

    British journal of clinical pharmacology·2012
    Same author

    Parkinsonism-physiology and pharmacology.

    British medical journal·2010
    Same author

    German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.

    Parkinsonism & related disorders·2008
    Same author

    The role of the Lewy body in idiopathic Parkinsonism.

    Parkinsonism & related disorders·2008
    Same author

    The natural history of neurological manganism over 18 years.

    Parkinsonism & related disorders·2006
    Same author

    Autosomal dominant dystonia-plus with cerebral calcifications.

    Neurology·2006
    Same journal

    Practice Patterns and Care Gaps in Lennox Gastaut Syndrome: A call for Action.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
    Same journal

    Isolated Achiasma Discovered at Age 86: A Rare Cause of see-saw nystagmus and bitemporal hemianopia.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
    Same journal

    Post-Stroke Parakinesia Brachialis Oscitans: Clinical Insights from a Case Series.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
    Same journal

    A Neuronal Perspective.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
    Same journal

    Diagnostic efficacy, costs, and safety of portable ultra-low field MRI in brain imaging: a systematic review.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
    Same journal

    Chronology of Non-Motor Symptoms in 100 Patients with Advanced PD of 10 Years' Duration: Pre- versus Post-Motor Period.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Parkinson's disease (PD) management has evolved significantly with levodopa.
    • Limitations of current levodopa therapy are increasingly recognized.

    Purpose of the Study:

    • To review current knowledge on Parkinson's disease etiology and pathophysiology.
    • To discuss practical approaches to drug therapy for Parkinson's disease.

    Main Methods:

    • Literature review of Parkinson's disease etiology.
    • Review of Parkinson's disease pathophysiology.
    • Analysis of current drug therapy strategies.

    Main Results:

    • Levodopa therapy has improved Parkinson's disease outcomes.
    • Significant challenges and limitations exist with levodopa treatment.

    Related Experiment Videos

  • Understanding of PD etiology and pathophysiology continues to advance.

    • Conclusions:

    • Further research into Parkinson's disease mechanisms is needed.
    • Optimizing drug therapy requires addressing levodopa's limitations.
    • Comprehensive management strategies are essential for Parkinson's disease patients.